BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 20160103)

  • 1. Cellular in vivo imaging reveals coordinated regulation of pituitary microcirculation and GH cell network function.
    Lafont C; Desarménien MG; Cassou M; Molino F; Lecoq J; Hodson D; Lacampagne A; Mennessier G; El Yandouzi T; Carmignac D; Fontanaud P; Christian H; Coutry N; Fernandez-Fuente M; Charpak S; Le Tissier P; Robinson IC; Mollard P
    Proc Natl Acad Sci U S A; 2010 Mar; 107(9):4465-70. PubMed ID: 20160103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GH in the dwarf dopaminergic D2 receptor knockout mouse: somatotrope population, GH release, and responsiveness to GH-releasing factors and somatostatin.
    García-Tornadú I; Rubinstein M; Gaylinn BD; Hill D; Arany E; Low MJ; Díaz-Torga G; Becu-Villalobos D
    J Endocrinol; 2006 Sep; 190(3):611-9. PubMed ID: 17003262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of GHRH and GHRP-2 treatment in vitro on GH secretion and levels of GH, pituitary transcription factor-1, GHRH-receptor, GH-secretagogue-receptor and somatostatin receptor mRNAs in ovine pituitary cells.
    Yan M; Hernandez M; Xu R; Chen C
    Eur J Endocrinol; 2004 Feb; 150(2):235-42. PubMed ID: 14763922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oestrogen replacement in vivo rescues the dysfunction of pituitary somatotropes in ovariectomised aromatase knockout mice.
    Yan M; Jones ME; Hernandez M; Liu D; Simpson ER; Chen C
    Neuroendocrinology; 2005; 81(3):158-66. PubMed ID: 16015026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression analysis of hypothalamic and pituitary components of the growth hormone axis in fasted and streptozotocin-treated neuropeptide Y (NPY)-intact (NPY+/+) and NPY-knockout (NPY-/-) mice.
    Park S; Peng XD; Frohman LA; Kineman RD
    Neuroendocrinology; 2005; 81(6):360-71. PubMed ID: 16244497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pulsatile GH secretion in acromegaly: hypothalamic or pituitary origin?
    Riedel M; Günther T; von zur Mühlen A; Brabant G
    Clin Endocrinol (Oxf); 1992 Sep; 37(3):233-9. PubMed ID: 1358484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulational effect of ghrelin on growth hormone secretion from perifused rat anterior pituitary cells.
    Yamazaki M; Nakamura K; Kobayashi H; Matsubara M; Hayashi Y; Kangawa K; Sakai T
    J Neuroendocrinol; 2002 Feb; 14(2):156-62. PubMed ID: 11849375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neonatal treatment with monosodium glutamate: effects of prolonged growth hormone (GH)-releasing hormone deficiency on pulsatile GH secretion and growth in female rats.
    Maiter D; Underwood LE; Martin JB; Koenig JI
    Endocrinology; 1991 Feb; 128(2):1100-6. PubMed ID: 1989848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different degrees of somatotroph ablation compromise pituitary growth hormone cell network structure and other pituitary endocrine cell types.
    Waite E; Lafont C; Carmignac D; Chauvet N; Coutry N; Christian H; Robinson I; Mollard P; Le Tissier P
    Endocrinology; 2010 Jan; 151(1):234-43. PubMed ID: 19887571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The growth hormone (GH)-axis of GH receptor/binding protein gene-disrupted and metallothionein-human GH-releasing hormone transgenic mice: hypothalamic neuropeptide and pituitary receptor expression in the absence and presence of GH feedback.
    Peng XD; Park S; Gadelha MR; Coschigano KT; Kopchick JJ; Frohman LA; Kineman RD
    Endocrinology; 2001 Mar; 142(3):1117-23. PubMed ID: 11181526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recruiting of somatotroph cells after combined somatostatin, GHRH and growth hormone (GH) secretagogue stimulation in a study of pituitary GH reserve in prepuberal female rats.
    Jiménez-Reina L; García-Martínez E; Rojas JP; Cañete MD; Bernal G; Cañete R
    Histol Histopathol; 2006 Oct; 21(10):1103-10. PubMed ID: 16835832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of cyclic AMP- and calcium-dependent mechanisms in the regulation of growth hormone-releasing hormone-stimulated growth hormone release from ovine pituitary cells.
    Sartin JL; Coleman ES; Steele B
    Domest Anim Endocrinol; 1996 May; 13(3):229-38. PubMed ID: 8738864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nutrient Sensing Overrides Somatostatin and Growth Hormone-Releasing Hormone to Control Pulsatile Growth Hormone Release.
    Steyn FJ
    J Neuroendocrinol; 2015 Jul; 27(7):577-87. PubMed ID: 25808924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pituitary responsiveness to GH-releasing hormone, GH-releasing peptide-2 and thyrotrophin-releasing hormone in critical illness.
    Van den Berghe G; de Zegher F; Bowers CY; Wouters P; Muller P; Soetens F; Vlasselaers D; Schetz M; Verwaest C; Lauwers P; Bouillon R
    Clin Endocrinol (Oxf); 1996 Sep; 45(3):341-51. PubMed ID: 8949573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV gp120 inhibits the somatotropic axis: a possible GH-releasing hormone receptor mechanism for the pathogenesis of AIDS wasting.
    Mulroney SE; McDonnell KJ; Pert CB; Ruff MR; Resch Z; Samson WK; Lumpkin MD
    Proc Natl Acad Sci U S A; 1998 Feb; 95(4):1927-32. PubMed ID: 9465119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is GHRH receptor essential to GHRP-2-induced GH secretion in primary cultured rat pituitary cells?
    Roh SG; Chen C; Choi KC; Shrestha Y; Sasaki S
    Endocrinology; 2002 May; 143(5):1964-7. PubMed ID: 11956179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increase in mRNA concentrations of pituitary receptors for growth hormone-releasing hormone and growth hormone secretagogues after neonatal monosodium glutamate treatment.
    Kovacs M; Kineman RD; Schally AV; Flerko B; Frohman LA
    J Neuroendocrinol; 2000 Apr; 12(4):335-41. PubMed ID: 10718930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone (GH)-releasing hormone (GHRH) and the GH secretagogue (GHS), L692,585, differentially modulate rat pituitary GHS receptor and GHRH receptor messenger ribonucleic acid levels.
    Kineman RD; Kamegai J; Frohman LA
    Endocrinology; 1999 Aug; 140(8):3581-6. PubMed ID: 10433214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The sequential administration of growth hormone-releasing hormone followed 120 minutes later by hexarelin, as an effective test to assess the pituitary GH reserve in man.
    Micic D; Popovic V; Kendereski A; Peino R; Dieguez C; Casanueva FF
    Clin Endocrinol (Oxf); 1996 Nov; 45(5):543-51. PubMed ID: 8977750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence that diminished pituitary responsivity to GHRF is secondary to intracellular GH pool depletion.
    Richardson SB; Twente S
    Am J Physiol; 1988 Mar; 254(3 Pt 1):E358-64. PubMed ID: 3126669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.